About Catherine Mott
Form D filings for CytoAgents from 2021 to 2023 list Catherine Mott as director.
Catherine Mott first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Catherine Mott in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Catherine Mott works with at each company, as listed on that company's latest Form D.
CytoAgents, Inc. · Form D, May 16, 2023
RP
Roy Prieb
Chief Financial Officer
RF
Robert Ferris
Director
SM
Stanley Marks
Director
TW
Teresa Whalen
Chief Executive Officer and President, director
AM
Anthony McCarley
Director